RM-END / Endocrine and peptide-hormone analogs
Vesilut
Also known as: Vesilute · ED peptide (market usage) · Glu-Asp (market usage)
Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.
What this is
Vesilut is not yet a stable chemical identity. Current market pages conflict between the ED dipeptide and the KED tripeptide already indexed here as Vesugen.
Evidence position
Grade U prevents evidence laundering across names. A supplier must state the full sequence and terminal form before any ED, KED or tissue-extract literature can be connected to the material.
What the record does not establish
Market repetition does not create chemical identity. The record does not establish activity, safety, approved use or the contents of a supplier lot.
Sources
- 01Glu-Asp chemical identityPubChem
- Shows
- Registry identity for L-alpha-glutamyl-L-aspartic acid
- Does not show
- Does not link the Vesilut market name to this exact molecule
- 02Vesilute market assignment to Glu-AspBioLongevity Labs
- Shows
- Current supplier-market usage assigning Vesilute to the ED dipeptide
- Does not show
- Supplier-authored secondary content; not an identity authority or direct primary study
- 03Conflicting Vesilut assignment to Lys-Glu-AspAminoCore
- Shows
- Current supplier page assigns the Vesilut name to KED and also calls it Vesugen
- Does not show
- Supplier-authored secondary content, included to document the conflict—not to validate KED
External database index
LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE
Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.
PUBCHEM / IDENTITY
L-alpha-Glutamyl-L-aspartic acid
- CID
- 99716
- Formula
- C9H14N2O7
- Mass
- 262.22